# Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer

> **NCT01715129** · PHASE3 · COMPLETED · sponsor: **Ipsen** · enrollment: 126 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Triptorelin Pamoate 11.25mg

## Key facts

- **NCT ID:** NCT01715129
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2019-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01715129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01715129, "Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01715129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*